Joaquín Bermejo

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

A. Oliver, E. Pérez-Nadales, R. Bonomo, 2017, The Lancet. Infectious diseases.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, R. Bonomo, Y. Carmeli, 2018, International journal of antimicrobial agents.

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae

A. Oliver, R. Bonomo, Y. Carmeli, 2018, Infection Control & Hospital Epidemiology.

[High relationship between ciprofloxacin use and prevalence of ESBL Klebsiella pneumoniae].

R. Notario, N. Borda, Nora Arnesi, 2006, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Mayo Clinic proceedings.